[...] there has been a lot of focus on the internal and external design issues of needleless connectors and a growing realization that although the current generation of needleless connectors protects the healthcare worker, they can be a source that is increasing the cause of central line associated bloodstream infections. The next wave of technology is to bring tip navigation systems from avoiding obvious malpositions to more accurately identifying the lower one third of the superior vena cava, near the cavalatrial junction.
P R E S I D E N T ’ S M E S S A G E Nadine Nakazawa, RN, BS, OCN B y the time this column is published, we will be con- volumes, chlorhexidine impregnated dressings, coated cathe- vening our annual conference. This has been a difﬁcult ters), but we do not have adequate technologies or strategies to and challenging year economically for our country, and prevent or manage intraluminal microbial colonization. There severe cutbacks in all areas have been experienced. With job are a number of antimicrobial locks in clinical trials and we losses, comes loss of health insurance and the ranks of the un- anxiously await these results. Will they be as efﬁcacious as we insured continue to climb. College graduates are experiencing hope? Will they be easy to use across the continuum of care? one of the most challenging job markets in decades, and jobs Will they be affordable? with health care beneﬁts are scarce. We are seeing increasing focus on venous thrombosis, the We have seen IV and PICC teams getting their positions and damage to the vasculature that occurs with repeated insertions budgets slashed, and adequate vascular access becomes ever of central venous access devices, and poor tip placements. The more challenging in our most seriously and chronically ill pa- next wave of technology is to bring tip navigation systems from tients. There are a number of national initiatives focusing on avoiding obvious malpositions to more accurately identifying reducing “errors” in healthcare, putting needed attention on the lower one third of the superior vena cava, near the caval- vascular access. It is unfortunate that pressure has to be placed atrial junction. We anxiously await the results of the clinical on healthcare systems in a negative way in order to get the fo- trials of a number of innovative and advancing technologies. cus and attention on our area of specialty. There remain many questions about what the best practice is In response to identiﬁed vascular access issues, we see on the with vascular access. We encourage you to ask the key ques- horizon innovative technologies that will help address some
Pages to are hidden for
"PRESIDENT'S MESSAGE"Please download to view full document